Citing numerous scientific errors and misinformation, the American Botanical Council (ABC; Austin, TX) and the Council for Responsible Nutrition (CRN; Washington, DC) have responded to an article on herbal products and patients with heart disease published in the current issue of the Journal of the American College of Cardiology.
Citing numerous scientific errors and misinformation, the American Botanical Council (ABC; Austin, TX) and the Council for Responsible Nutrition (CRN; Washington, DC) have responded to an article on herbal products and patients with heart disease published in the current issue of the Journal of the American College of Cardiology.
The article, 'Use of Herbal Products and Potential Interactions in Patients With Cardiovascular Diseases,'ÃÂ reviewed common herbs and herbal supplements, and the effects they may have on factors related to heart disease and drug interaction. Both associations noted that the article includes factual errors, generalizations not backed by proper citations, and other serious flaws.
ABC noted that the article...s review of 'commonly used herbs'ÃÂ includes toxic herbs and plants not approved for the U.S. dietary supplement market, such as the toxic plant oleander (Nerium oleander), an ingredient presumed to be dried Chinese toad venom, and uzara root (Xysmalobium undulatum), an antidiarrhea herbal drug approved for use in Germany. Both associations... press releases report a number of other instances of misinformation.
'The article contains sweeping generalizations"including a reference to products'”some of which are not actually herbal supplements'”that produce adverse effects on the cardiovascular system,'ÃÂ noted CRN vice president of scientific and regulatory affairs, Douglas MacKay, ND.
'Many herbal supplements offer healthful benefits,'ÃÂ added MacKay. 'Fiber, garlic, and Hawthorne provide heart health benefits, and the potential risk for a drug interaction can be eliminated by speaking openly with your doctor.'ÃÂ
To read an abstract of the study, click here.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.
Recent review makes the case for testing omega-3 fatty acid levels in humans
May 23rd 2024The article commissioned by The Global Organization for EPA and DHA Omega-3s (GOED) reviewed the state of omega-3 fatty acid testing, highlighting the value of testing and the commercially available options for diagnostic testing.
Epax launches concentrated oil that combines omegas 3, 9, and 11
May 10th 2024The blend of long-chain polyunsaturated fatty acids and long-chain monounsaturated fatty acids combines the heart and brain health benefits of omegas-3s with the skin and metabolic health benefits of omegas 9 and 11.